[go: up one dir, main page]

TR199801650T2 - MMS n�rit b�y�me mod�lat�rleri ve bile�imleri. - Google Patents

MMS n�rit b�y�me mod�lat�rleri ve bile�imleri.

Info

Publication number
TR199801650T2
TR199801650T2 TR1998/01650T TR9801650T TR199801650T2 TR 199801650 T2 TR199801650 T2 TR 199801650T2 TR 1998/01650 T TR1998/01650 T TR 1998/01650T TR 9801650 T TR9801650 T TR 9801650T TR 199801650 T2 TR199801650 T2 TR 199801650T2
Authority
TR
Turkey
Prior art keywords
rleri
imleri
rit
lat
mms
Prior art date
Application number
TR1998/01650T
Other languages
Turkish (tr)
Inventor
Schachner Melitta
Original Assignee
Acorda Therapeutics
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acorda Therapeutics filed Critical Acorda Therapeutics
Publication of TR199801650T2 publication Critical patent/TR199801650T2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5058—Neurological cells
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70503—Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Environmental Sciences (AREA)
  • Hematology (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)

Abstract

Bir memelinin merkezi sinir sisteminde, in vivo kosullar altinda nöral gelisimi desteklemeye yönelik, sözkonusu memeliye bir maddenin nöral gelisimi destekleyici miktarindan tatbik edilmesinden olusan bir metod; sözkonusu madde bir nöral hücre adhezyon molekülü, bunun aktif fragmanlari, kognatlari, kongenerleri, mimikleri, antagonistleri, buna yönelik antikorlari, analoglari, bunu salgilayan hücreleri ve çözünen moleküllerinden olusacak ve bu molekül glial hücreler ve myelin üzerinde bulunan baskilayici moleküller engelleri asabilecek ve sözkonusu nöral gelisimi saglayacaktir.A method for promoting neural development under conditions in vivo of a mammal's central nervous system; the substance will consist of a neural cell adhesion molecule, its active fragments, cognates, congeners, mimics, antagonists, antibodies directed thereto, analogs, cells secreting it, and dissolving molecules, and this molecule will suspend barriers to the glial cells and myelin. It will provide.

TR1998/01650T 1995-04-19 1996-04-19 MMS n�rit b�y�me mod�lat�rleri ve bile�imleri. TR199801650T2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42499595A 1995-04-19 1995-04-19
US48395995A 1995-06-07 1995-06-07

Publications (1)

Publication Number Publication Date
TR199801650T2 true TR199801650T2 (en) 1999-03-22

Family

ID=27026535

Family Applications (2)

Application Number Title Priority Date Filing Date
TR1998/01650T TR199801650T2 (en) 1995-04-19 1996-04-19 MMS n�rit b�y�me mod�lat�rleri ve bile�imleri.
TR97/01203T TR199701203T1 (en) 1995-04-19 1996-04-19 CNS n�rit b�y�me mod�lat�rleri ve bile�imleri.

Family Applications After (1)

Application Number Title Priority Date Filing Date
TR97/01203T TR199701203T1 (en) 1995-04-19 1996-04-19 CNS n�rit b�y�me mod�lat�rleri ve bile�imleri.

Country Status (15)

Country Link
EP (1) EP0821591A1 (en)
JP (1) JPH11504211A (en)
KR (1) KR19990007893A (en)
AU (1) AU718508B2 (en)
CA (1) CA2218599A1 (en)
CZ (1) CZ330197A3 (en)
EA (1) EA199700323A1 (en)
HU (1) HUP9900060A3 (en)
IS (1) IS4590A (en)
MX (1) MX9708127A (en)
NO (1) NO974811L (en)
PL (1) PL322947A1 (en)
SK (1) SK142497A3 (en)
TR (2) TR199801650T2 (en)
WO (1) WO1996032959A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2190418A1 (en) * 1996-11-15 1998-05-15 Zhi-Cheng Xiao Neuron and neural tumor growth regulatory system, antibodies thereto and uses thereof
EP0910641A1 (en) * 1997-02-13 1999-04-28 Smithkline Beecham Plc Neural cell adhesion molecule splicing variants
WO2000018801A2 (en) * 1998-09-29 2000-04-06 Roenn Lars Christian B Ncam binding compounds
AUPQ614200A0 (en) * 2000-03-10 2000-03-30 Department Of Human Physiology, Flinders University School Of Medicine Method for treating chronic spinal cord injury
US20020164668A1 (en) * 2000-04-03 2002-11-07 Durham L. Kathryn Nucleic acid molecules, polypeptides and uses therefor, including diagnosis and treatment of alzheimer's disease
SG121733A1 (en) * 2001-10-03 2006-05-26 Pfizer Prod Inc Nucleic acid molecules polypeptides and uses therefor, including diagnosis and treatment of alzheimer's disease
AR040778A1 (en) 2002-08-06 2005-04-20 Glaxo Group Ltd ALTERED ANTIBODIES OR FUNCTIONAL FRAGMENTS THAT BIND MAG (GLICOPROTEIN ASSOCIATED WITH HONEY).
US20040081653A1 (en) 2002-08-16 2004-04-29 Raitano Arthur B. Nucleic acids and corresponding proteins entitled 251P5G2 useful in treatment and detection of cancer
GB0306309D0 (en) 2003-03-19 2003-04-23 Glaxo Group Ltd Method of treatment
CA2807645C (en) 2009-08-07 2021-09-07 Affinimark Technologies, Inc. Device and methods for the immunological identification of cerebrospinal fluid

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100196540B1 (en) * 1988-11-04 1999-06-15 마틴 이. 샤브 Axon growth regulator
WO1993000427A2 (en) * 1991-06-24 1993-01-07 Erziehungsdirektion Of The Canton Zurich Neurite growth regulatory factors
CA2173731A1 (en) * 1993-11-08 1995-05-18 Martin Grumet Neuron-glia cell adhesion molecule, ng-cam, in treatment of nerve damage

Also Published As

Publication number Publication date
SK142497A3 (en) 1999-08-06
CZ330197A3 (en) 1998-04-15
KR19990007893A (en) 1999-01-25
NO974811L (en) 1997-12-19
JPH11504211A (en) 1999-04-20
EA199700323A1 (en) 1998-04-30
TR199701203T1 (en) 1998-03-21
AU5557296A (en) 1996-11-07
MX9708127A (en) 1998-06-28
HUP9900060A3 (en) 2001-08-28
WO1996032959A1 (en) 1996-10-24
PL322947A1 (en) 1998-03-02
NO974811D0 (en) 1997-10-17
IS4590A (en) 1997-10-15
AU718508B2 (en) 2000-04-13
CA2218599A1 (en) 1996-10-24
HUP9900060A2 (en) 1999-04-28
EP0821591A1 (en) 1998-02-04

Similar Documents

Publication Publication Date Title
TR199801650T2 (en) MMS n�rit b�y�me mod�lat�rleri ve bile�imleri.
Yamada Fibronectin peptides in cell migration and wound repair
DE69204834D1 (en) LINKED MEMBRANE ELECTRODE ARRANGEMENT FOR ELECTROCHEMICAL FUEL CELL.
DE59603513D1 (en) ELECTRODE SUBSTRATE FOR FUEL CELL
ATE369878T1 (en) CARRIER-PHARMACY CONJUGATES
CY1109367T1 (en) COMPOSITIONS AND METHODS FOR STRENGTHENING THERAPEUTIC INDICATORS
DE69631900D1 (en) ELECTRODE MATERIAL FOR ELECTROCHEMICAL LITHIUM INSERTION
DE3881941D1 (en) ELECTRODE SUBSTRATE FOR FUEL CELL AND METHOD FOR THE PRODUCTION THEREOF.
NO980957D0 (en) Cell cycle checkpoint genes
DE50113568D1 (en) ANTISENSE OLIGONUCLEOTIDES AGAINST VR 1
DE69005703D1 (en) Electrode for electrochemical sensors.
ATE368054T1 (en) COMPOUNDS AND METHODS FOR MODULATING OCCLUDIN-DEPENDENT TISSUE PERMEABILITY
DE3874498D1 (en) COMBINATIONS OF ELECTROCHEMICAL CELLS OF LONG-TERM FORM.
NO893216L (en) ELECTROCHEMICAL GENERATOR.
DE60336149D1 (en) Highly reactive and soluble crosslinkers and their use in the preparation of conjugates for the targeted delivery of small-molecule drugs
DE69511585D1 (en) LATERAL DISTRIBUTOR ARRANGEMENT FOR ELECTROCHEMICAL FUEL CELL STACKS
DE59307434D1 (en) Centrally symmetrical fuel cell battery
TR200401348T4 (en) Electrical contact for control of artificial fiber ropes
DE69606106D1 (en) Negative active mass suitable for unsintered nickel electrodes for alkaline batteries
Norris et al. Identification of motor neurons that contain a FMRFamidelike peptide and the effects of FMRFamide on longitudinal muscle in the medicinal leech, Hirudo medicinalis
NO875040L (en) Self-supporting Fuel Cell Electrode.
NO305819B1 (en) Central symmetrical fuel cell battery
DE68909959D1 (en) Circuit for sensing the state of matrix cells in MOS-EPROM memories.
ATE227996T1 (en) COMPOSITION AND METHOD FOR REGULATING CELL PROLIFERATION AND CELL DEATH
DE69840578D1 (en) MANNOSIS RECEPTOR CARRYING CELL LINE AND ANTIGEN COMPOSITION